$MDGL: Here’s Why Madrigal Pharmaceuticals Fell 39.4% in November

Date: Saturday, December 8th, 2018

Stock(s) mentioned:

Source: Motley Fool (https://www.fool.com)

Summary: Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL), a clinical-stage biotechnology company, fell 39.4% in November, according to data from S&P Global …

Full article address: https://www.fool.com/investing/2018/12/08/heres-why-madrigal-pharmaceuticals-fell-394-in-nov.aspx

Related News:

$IRWD $MDGL: Analysts Lower Expectations on Pharma Stocks IRWD and MDGL

$MDGL: Phase 2 Results for Madrigal’s MGL-3196 in Non-Alcoholic …

$ICPT $MDGL: Better Buy: Intercept Pharmaceuticals Inc. vs. Madrigal …

$MDGL: Madrigal Pharmaceuticals Presents Buying Opportunity Before Data …

$VKTX $MDGL $SPX $DJIA: Viking Therapeutics stock rose 87% on results for its liver disease drug — and the company has more in store this fall

$MDGL $PFE: 4 Biotech Stocks With Leaky Pipelines

Latest News:

$PRU: First ESG equity strategy added to PGIM Investments UCITS platform …

$PTEN $CUZ $ICPT: Hedge Funds Aren’t Crazy About Eldorado Resorts Inc (ERI) Anymore

$EEFT $EPR: Should You Buy Euronet Worldwide, Inc. (EEFT)?

$FAF: First American Financial Corp (FAF): Are Hedge Funds Right About …

$MO $CRON: Cannabis Starts To Copy Tech’s Indian Rope Trick

$SYMC $AEG: Do Hedge Funds Love Symantec Corporation (SYMC)?

$ATORX: Alligator Bioscience Starts Clinical Phase I Study With ATOR-1015

$ISBC $SF: Is Investors Bancorp, Inc. (ISBC) A Good Stock To Buy?

$GLPI $ZEN: Hedge Funds Are Betting On Gaming and Leisure Properties Inc …

$MAC $BPY: Is The Macerich Company (MAC) A Good Stock To Buy?

$HP $MSG $EPAM: Helmerich & Payne, Inc. (HP): Are Hedge Funds Right About This …